Stocks and Investing
by (remove) : Kennen MacKay
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Kennen MacKay
RSSJSONXMLCSV
Tue, June 27, 2023
Fri, August 5, 2022
Fri, February 25, 2022
Tue, December 21, 2021
Wed, November 3, 2021
Mon, August 9, 2021
Thu, July 29, 2021
Wed, April 28, 2021
Thu, August 20, 2020
Fri, May 8, 2020
Wed, March 18, 2020
Fri, January 24, 2020
Wed, April 4, 2018
Fri, September 15, 2017
Tue, February 21, 2017
Mon, January 23, 2017
Tue, March 22, 2016
Thu, March 3, 2016
Fri, February 26, 2016
Thu, June 18, 2015

Kennen MacKay Maintained (AGIO) at Buy with Increased Target to $42 on, Jun 27th, 2023


Published on 2024-10-28 04:31:24 - WOPRAI, Kennen MacKay
  Print publication without navigation


Kennen MacKay of RBC Capital, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Increased Target from $40 to $42 on, Jun 27th, 2023.

Kennen, nor any peers, have made any analyst calls on AGIO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources